Recall Register

Food, drugs, devices › GlaxoSmithKline, LLC

Drug recall: Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhaler

FDA enforcement event 76839 · Class II · initiated 22 Mar 2017 · status Ongoing

DrugVoluntary: Firm initiated1 product recordZebulon, NC

GlaxoSmithKline, LLC (Zebulon, NC) initiated this drug recall on 22 Mar 2017; FDA lists 1 product record under event 76839, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 57% of the 343 drug enforcement events initiated in 2017 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. GlaxoSmithKline, LLC has 13 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

GlaxoSmithKline, LLC, Zebulon, NC.

Reason for recall

"Defective Delivery System: Elevated number of units with out of specification results for leak rate."

Distribution

"Nationwide in the USA and Puerto Rico"

Product records

Recall numberProductQuantityClassStatusReport date
D-0626-2017Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline, Research Triangle Park, NC 22709, NDC 0173-0682-20.593,088 inhalersClass IIOngoing12 Apr 2017

Context

57%of 2017 drug events are Class II343 events that year
1product record in this eventfirm median: 1
13events on this register for the firm

Other enforcement events for GlaxoSmithKline, LLC

InitiatedProduct (first record)TypeClassRecords
17 May 2024Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tableDrugClass III1
12 Dec 2023ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters tDrugClass III1
13 May 2022Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 497DrugClass III1
16 May 2017Ventolin HFA (albuterol sulfate) Inhalation, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx onDrugClass II1
18 Jul 2016Bactroban Cream, (Mupirocin Calcium Cream 2%), 15 gram tube, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709,DrugClass II4
3 Dec 2015Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Rx Only, For Oral IDrugClass II1
13 Aug 2015Bactroban (mupirocin calcium) Nasal Ointment, 2% 1g tube, Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire RoadDrugClass II4
6 Nov 2013Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each containinDrugClass II2
17 Oct 2013Biotene Moisturizing Mouth Spray, with xylitol, For dry mouth symptom relief, 44.3ml/1.5 FL. OZ., Sugar Free Sweetened wDeviceClass II1
18 Jul 2013TUMS, Antacid/Calcium Supplement, ULTRA Strength 1000, Assorted Berries, 72 Chewable Tablets, GlaxoSmithKline, Moon Twp,DrugClass III1

All 13 events for GlaxoSmithKline, LLC

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Defective Delivery System: Elevated number of units with out of specification results for leak rate."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide in the USA and Puerto Rico"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.